Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
7.10
+0.34 (5.03%)
Feb 18, 2026, 4:00 PM EST - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $355.25 million as of February 18, 2026. Its market cap has increased by 80.50% in one year.
Market Cap
355.25M
Enterprise Value
160.13M
1-Year Change
80.50%
Ranking
Category
Stock Price
$7.10
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $355.25M, an increase of 289.98%. That is a compound annual growth rate of 29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 355.25M | -12.97% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 373.37M |
| Bicycle Therapeutics | 373.20M |
| Monopar Therapeutics | 370.75M |
| Benitec Biopharma | 362.07M |
| Adlai Nortye | 361.99M |
| Atea Pharmaceuticals | 359.77M |
| Protara Therapeutics | 357.43M |
| Vanda Pharmaceuticals | 356.42M |